General Information of the Compound
Compound ID |
CP0042977
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
9-cis retinoic acid
Show/Hide
|
||||||||||||||||||
Synonyms |
Alitretinoin
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C20H28O2
|
||||||||||||||||||
Molecular Weight |
300.442
|
||||||||||||||||||
Canonical SMILES |
C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+
Show/Hide
|
||||||||||||||||||
InChIKey |
SHGAZHPCJJPHSC-ZVCIMWCZSA-N
|
||||||||||||||||||
CAS |
5300-03-8
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01475, Retinoic acid receptor alpha
Protein ID: PT01452, Retinoic acid receptor beta
Protein ID: PT01806, Retinoic acid receptor gamma
Protein ID: PT01930, Retinoic acid receptor RXR-alpha
Cell-based Assay
Biochemical Assays
Protein ID: PT04149, Retinoic acid receptor RXR-alpha
Protein ID: PT03152, Retinoic acid receptor RXR-alpha
Protein ID: PT01474, Retinoic acid receptor RXR-beta
Protein ID: PT02538, Retinoic acid receptor RXR-beta
Protein ID: PT02226, Retinoic acid receptor RXR-gamma
Protein ID: PT02769, Retinoic acid receptor RXR-gamma
Clinical Information about the Compound
Drug 1 ( Alitretinoin )
Drug Name | Alitretinoin | ||
---|---|---|---|
Company | Ligand Pharmaceuticals | ||
Indication | |||
Target(s) |
Retinoic acid receptor gamma (RARG)
Modulator
|